Global Bisphosphonate Drugs Sales Market Report 2016

Publisher Name :
Date: 09-Dec-2016
No. of pages: 117
Inquire Before Buying

Notes:

Sales, means the sales volume of Bisphosphonate Drugs

Revenue, means the sales value of Bisphosphonate Drugs

This report studies sales (consumption) of Bisphosphonate Drugs in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

- Pfizer Inc. (USA)

- Abbott Laboratories (USA)

- Merck & Co., Inc. (US)

- GlaxoSmithKline Plc (UK)

- Sanofi SA (France)

- Indevus Pharmaceuticals Inc. (USA)

- Decartis AG (Switzerland)

- OSI Pharmaceuticals, Inc. (USA)

- Paladin Labs Inc. (Canada)

- ALZA Corporation (USA)

- Eli Lilly and Company (US)

- AstraZeneca PLC (UK)

- Medimmune, LLC (USA)

- Bristol-Myers Squibb Company (USA)

- Cell Genesys Inc. (USA)

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Bisphosphonate Drugs in these regions, from 2011 to 2021 (forecast), like

- United States

- China

- Europe

- Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Bisphosphonate Drugs in each application, can be divided into

- Application 1

- Application 2

- Application 3

Global Bisphosphonate Drugs Sales Market Report 2016

Table of Contents
Global Bisphosphonate Drugs Sales Market Report 2016
1 Bisphosphonate Drugs Overview
1.1 Product Overview and Scope of Bisphosphonate Drugs
1.2 Classification of Bisphosphonate Drugs
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Bisphosphonate Drugs
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Bisphosphonate Drugs Market by Regions
1.4.1 United States Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Bisphosphonate Drugs (2011-2021)
1.5.1 Global Bisphosphonate Drugs Sales and Growth Rate (2011-2021)
1.5.2 Global Bisphosphonate Drugs Revenue and Growth Rate (2011-2021)
2 Global Bisphosphonate Drugs Competition by Manufacturers, Type and Application
2.1 Global Bisphosphonate Drugs Market Competition by Manufacturers
2.1.1 Global Bisphosphonate Drugs Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Bisphosphonate Drugs Revenue and Share by Manufacturers (2011-2016)
2.2 Global Bisphosphonate Drugs (Volume and Value) by Type
2.2.1 Global Bisphosphonate Drugs Sales and Market Share by Type (2011-2016)
2.2.2 Global Bisphosphonate Drugs Revenue and Market Share by Type (2011-2016)
2.3 Global Bisphosphonate Drugs (Volume and Value) by Regions
2.3.1 Global Bisphosphonate Drugs Sales and Market Share by Regions (2011-2016)
2.3.2 Global Bisphosphonate Drugs Revenue and Market Share by Regions (2011-2016)
2.4 Global Bisphosphonate Drugs (Volume) by Application
3 United States Bisphosphonate Drugs (Volume, Value and Sales Price)
3.1 United States Bisphosphonate Drugs Sales and Value (2011-2016)
3.1.1 United States Bisphosphonate Drugs Sales and Growth Rate (2011-2016)
3.1.2 United States Bisphosphonate Drugs Revenue and Growth Rate (2011-2016)
3.1.3 United States Bisphosphonate Drugs Sales Price Trend (2011-2016)
3.2 United States Bisphosphonate Drugs Sales and Market Share by Manufacturers
3.3 United States Bisphosphonate Drugs Sales and Market Share by Type
3.4 United States Bisphosphonate Drugs Sales and Market Share by Application
4 China Bisphosphonate Drugs (Volume, Value and Sales Price)
4.1 China Bisphosphonate Drugs Sales and Value (2011-2016)
4.1.1 China Bisphosphonate Drugs Sales and Growth Rate (2011-2016)
4.1.2 China Bisphosphonate Drugs Revenue and Growth Rate (2011-2016)
4.1.3 China Bisphosphonate Drugs Sales Price Trend (2011-2016)
4.2 China Bisphosphonate Drugs Sales and Market Share by Manufacturers
4.3 China Bisphosphonate Drugs Sales and Market Share by Type
4.4 China Bisphosphonate Drugs Sales and Market Share by Application
5 Europe Bisphosphonate Drugs (Volume, Value and Sales Price)
5.1 Europe Bisphosphonate Drugs Sales and Value (2011-2016)
5.1.1 Europe Bisphosphonate Drugs Sales and Growth Rate (2011-2016)
5.1.2 Europe Bisphosphonate Drugs Revenue and Growth Rate (2011-2016)
5.1.3 Europe Bisphosphonate Drugs Sales Price Trend (2011-2016)
5.2 Europe Bisphosphonate Drugs Sales and Market Share by Manufacturers
5.3 Europe Bisphosphonate Drugs Sales and Market Share by Type
5.4 Europe Bisphosphonate Drugs Sales and Market Share by Application
6 Japan Bisphosphonate Drugs (Volume, Value and Sales Price)
6.1 Japan Bisphosphonate Drugs Sales and Value (2011-2016)
6.1.1 Japan Bisphosphonate Drugs Sales and Growth Rate (2011-2016)
6.1.2 Japan Bisphosphonate Drugs Revenue and Growth Rate (2011-2016)
6.1.3 Japan Bisphosphonate Drugs Sales Price Trend (2011-2016)
6.2 Japan Bisphosphonate Drugs Sales and Market Share by Manufacturers
6.3 Japan Bisphosphonate Drugs Sales and Market Share by Type
6.4 Japan Bisphosphonate Drugs Sales and Market Share by Application
7 Global Bisphosphonate Drugs Manufacturers Analysis
7.1 Pfizer Inc. (USA)
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Bisphosphonate Drugs Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Pfizer Inc. (USA) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
7.1.4 Main Business/Business Overview
7.2 Abbott Laboratories (USA)
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 117 Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Abbott Laboratories (USA) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
7.2.4 Main Business/Business Overview
7.3 Merck & Co., Inc. (US)
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 135 Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Merck & Co., Inc. (US) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
7.3.4 Main Business/Business Overview
7.4 GlaxoSmithKline Plc (UK)
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Dec Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 GlaxoSmithKline Plc (UK) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
7.4.4 Main Business/Business Overview
7.5 Sanofi SA (France)
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Sanofi SA (France) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
7.5.4 Main Business/Business Overview
7.6 Indevus Pharmaceuticals Inc. (USA)
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Million USD Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Indevus Pharmaceuticals Inc. (USA) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
7.6.4 Main Business/Business Overview
7.7 Decartis AG (Switzerland)
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Pharma & Healthcare Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Decartis AG (Switzerland) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
7.7.4 Main Business/Business Overview
7.8 OSI Pharmaceuticals, Inc. (USA)
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 OSI Pharmaceuticals, Inc. (USA) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
7.8.4 Main Business/Business Overview
7.9 Paladin Labs Inc. (Canada)
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Paladin Labs Inc. (Canada) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
7.9.4 Main Business/Business Overview
7.10 ALZA Corporation (USA)
7.10.1 Company Basic Information, Manufacturing Base and Competitors
7.10.2Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 ALZA Corporation (USA) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
7.10.4 Main Business/Business Overview
7.11 Eli Lilly and Company (US)
7.12 AstraZeneca PLC (UK)
7.13 Medimmune, LLC (USA)
7.14 Bristol-Myers Squibb Company (USA)
7.15 Cell Genesys Inc. (USA)
8 Bisphosphonate Drugs Maufacturing Cost Analysis
8.1 Bisphosphonate Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Process Analysis of Bisphosphonate Drugs
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Bisphosphonate Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Bisphosphonate Drugs Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Bisphosphonate Drugs Market Forecast (2016-2021)
12.1 Global Bisphosphonate Drugs Sales, Revenue Forecast (2016-2021)
12.2 Global Bisphosphonate Drugs Sales Forecast by Regions (2016-2021)
12.3 Global Bisphosphonate Drugs Sales Forecast by Type (2016-2021)
12.4 Global Bisphosphonate Drugs Sales Forecast by Application (2016-2021)
13 Appendix
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of Bisphosphonate Drugs
Table Classification of Bisphosphonate Drugs
Figure Global Sales Market Share of Bisphosphonate Drugs by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Bisphosphonate Drugs
Figure Global Sales Market Share of Bisphosphonate Drugs by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Bisphosphonate Drugs Revenue and Growth Rate (2011-2021)
Figure China Bisphosphonate Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Bisphosphonate Drugs Revenue and Growth Rate (2011-2021)
Figure Japan Bisphosphonate Drugs Revenue and Growth Rate (2011-2021)
Figure Global Bisphosphonate Drugs Sales and Growth Rate (2011-2021)
Figure Global Bisphosphonate Drugs Revenue and Growth Rate (2011-2021)
Table Global Bisphosphonate Drugs Sales of Key Manufacturers (2011-2016)
Table Global Bisphosphonate Drugs Sales Share by Manufacturers (2011-2016)
Figure 2015 Bisphosphonate Drugs Sales Share by Manufacturers
Figure 2016 Bisphosphonate Drugs Sales Share by Manufacturers
Table Global Bisphosphonate Drugs Revenue by Manufacturers (2011-2016)
Table Global Bisphosphonate Drugs Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Bisphosphonate Drugs Revenue Share by Manufacturers
Table 2016 Global Bisphosphonate Drugs Revenue Share by Manufacturers
Table Global Bisphosphonate Drugs Sales and Market Share by Type (2011-2016)
Table Global Bisphosphonate Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Bisphosphonate Drugs by Type (2011-2016)
Figure Global Bisphosphonate Drugs Sales Growth Rate by Type (2011-2016)
Table Global Bisphosphonate Drugs Revenue and Market Share by Type (2011-2016)
Table Global Bisphosphonate Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Bisphosphonate Drugs by Type (2011-2016)
Figure Global Bisphosphonate Drugs Revenue Growth Rate by Type (2011-2016)
Table Global Bisphosphonate Drugs Sales and Market Share by Regions (2011-2016)
Table Global Bisphosphonate Drugs Sales Share by Regions (2011-2016)
Figure Sales Market Share of Bisphosphonate Drugs by Regions (2011-2016)
Figure Global Bisphosphonate Drugs Sales Growth Rate by Regions (2011-2016)
Table Global Bisphosphonate Drugs Revenue and Market Share by Regions (2011-2016)
Table Global Bisphosphonate Drugs Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Bisphosphonate Drugs by Regions (2011-2016)
Figure Global Bisphosphonate Drugs Revenue Growth Rate by Regions (2011-2016)
Table Global Bisphosphonate Drugs Sales and Market Share by Application (2011-2016)
Table Global Bisphosphonate Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Bisphosphonate Drugs by Application (2011-2016)
Figure Global Bisphosphonate Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Bisphosphonate Drugs Sales and Growth Rate (2011-2016)
Figure United States Bisphosphonate Drugs Revenue and Growth Rate (2011-2016)
Figure United States Bisphosphonate Drugs Sales Price Trend (2011-2016)
Table United States Bisphosphonate Drugs Sales by Manufacturers (2011-2016)
Table United States Bisphosphonate Drugs Market Share by Manufacturers (2011-2016)
Table United States Bisphosphonate Drugs Sales by Type (2011-2016)
Table United States Bisphosphonate Drugs Market Share by Type (2011-2016)
Table United States Bisphosphonate Drugs Sales by Application (2011-2016)
Table United States Bisphosphonate Drugs Market Share by Application (2011-2016)
Figure China Bisphosphonate Drugs Sales and Growth Rate (2011-2016)
Figure China Bisphosphonate Drugs Revenue and Growth Rate (2011-2016)
Figure China Bisphosphonate Drugs Sales Price Trend (2011-2016)
Table China Bisphosphonate Drugs Sales by Manufacturers (2011-2016)
Table China Bisphosphonate Drugs Market Share by Manufacturers (2011-2016)
Table China Bisphosphonate Drugs Sales by Type (2011-2016)
Table China Bisphosphonate Drugs Market Share by Type (2011-2016)
Table China Bisphosphonate Drugs Sales by Application (2011-2016)
Table China Bisphosphonate Drugs Market Share by Application (2011-2016)
Figure Europe Bisphosphonate Drugs Sales and Growth Rate (2011-2016)
Figure Europe Bisphosphonate Drugs Revenue and Growth Rate (2011-2016)
Figure Europe Bisphosphonate Drugs Sales Price Trend (2011-2016)
Table Europe Bisphosphonate Drugs Sales by Manufacturers (2011-2016)
Table Europe Bisphosphonate Drugs Market Share by Manufacturers (2011-2016)
Table Europe Bisphosphonate Drugs Sales by Type (2011-2016)
Table Europe Bisphosphonate Drugs Market Share by Type (2011-2016)
Table Europe Bisphosphonate Drugs Sales by Application (2011-2016)
Table Europe Bisphosphonate Drugs Market Share by Application (2011-2016)
Figure Japan Bisphosphonate Drugs Sales and Growth Rate (2011-2016)
Figure Japan Bisphosphonate Drugs Revenue and Growth Rate (2011-2016)
Figure Japan Bisphosphonate Drugs Sales Price Trend (2011-2016)
Table Japan Bisphosphonate Drugs Sales by Manufacturers (2011-2016)
Table Japan Bisphosphonate Drugs Market Share by Manufacturers (2011-2016)
Table Japan Bisphosphonate Drugs Sales by Type (2011-2016)
Table Japan Bisphosphonate Drugs Market Share by Type (2011-2016)
Table Japan Bisphosphonate Drugs Sales by Application (2011-2016)
Table Japan Bisphosphonate Drugs Market Share by Application (2011-2016)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. (USA) Bisphosphonate Drugs Global Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (USA) Bisphosphonate Drugs Global Market Share (2011-2016)
Table Merck & Co., Inc. (US) Basic Information List
Table Merck & Co., Inc. (US) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co., Inc. (US) Bisphosphonate Drugs Global Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Plc (UK) Bisphosphonate Drugs Global Market Share (2011-2016)
Table Sanofi SA (France) Basic Information List
Table Sanofi SA (France) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi SA (France) Bisphosphonate Drugs Global Market Share (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information List
Table Indevus Pharmaceuticals Inc. (USA) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Indevus Pharmaceuticals Inc. (USA) Bisphosphonate Drugs Global Market Share (2011-2016)
Table Decartis AG (Switzerland) Basic Information List
Table Decartis AG (Switzerland) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Decartis AG (Switzerland) Bisphosphonate Drugs Global Market Share (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information List
Table OSI Pharmaceuticals, Inc. (USA) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure OSI Pharmaceuticals, Inc. (USA) Bisphosphonate Drugs Global Market Share (2011-2016)
Table Paladin Labs Inc. (Canada) Basic Information List
Table Paladin Labs Inc. (Canada) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Paladin Labs Inc. (Canada) Bisphosphonate Drugs Global Market Share (2011-2016)
Table ALZA Corporation (USA) Basic Information List
Table ALZA Corporation (USA) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure ALZA Corporation (USA) Bisphosphonate Drugs Global Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly and Company (US) Bisphosphonate Drugs Global Market Share (2011-2016)
Table AstraZeneca PLC (UK) Basic Information List
Table AstraZeneca PLC (UK) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca PLC (UK) Bisphosphonate Drugs Global Market Share (2011-2016)
Table Medimmune, LLC (USA) Basic Information List
Table Medimmune, LLC (USA) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Medimmune, LLC (USA) Bisphosphonate Drugs Global Market Share (2011-2016)
Table Bristol-Myers Squibb Company (USA) Basic Information List
Table Bristol-Myers Squibb Company (USA) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Company (USA) Bisphosphonate Drugs Global Market Share (2011-2016)
Table Cell Genesys Inc. (USA) Basic Information List
Table Cell Genesys Inc. (USA) Bisphosphonate Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Cell Genesys Inc. (USA) Bisphosphonate Drugs Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bisphosphonate Drugs
Figure Manufacturing Process Analysis of Bisphosphonate Drugs
Figure Bisphosphonate Drugs Industrial Chain Analysis
Table Raw Materials Sources of Bisphosphonate Drugs Major Manufacturers in 2015
Table Major Buyers of Bisphosphonate Drugs
Table Distributors/Traders List
Figure Global Bisphosphonate Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Global Bisphosphonate Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Bisphosphonate Drugs Sales Forecast by Regions (2016-2021)
Table Global Bisphosphonate Drugs Sales Forecast by Type (2016-2021)
Table Global Bisphosphonate Drugs Sales Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Global Vegetable (HPMC) Capsule Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 26-May-2017        Price: US 3480 Onwards        Pages: 116
    Hydroxypropyl methylcellulose is a methylcellulose modified with a small amount of propylene glycol ether groups attached to the anhydroglucose of the cellulose. HPMC Capsules are two-piece capsules made from cellulosic raw materials that satisfy vegetarian, religion, cultural and policy needs. These vegetable capsules are an attractive, all natural dosage form that retain all the advantages - easy to swallow, effectively mask taste and odor, and allow product visibility. These ca......
  • North America Vegetable (HPMC) Capsule Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 26-May-2017        Price: US 4480 Onwards        Pages: 116
    Hydroxypropyl methylcellulose is a methylcellulose modified with a small amount of propylene glycol ether groups attached to the anhydroglucose of the cellulose. HPMC Capsules are two-piece capsules made from cellulosic raw materials that satisfy vegetarian, religion, cultural and policy needs. These vegetable capsules are an attractive, all natural dosage form that retain all the advantages - easy to swallow, effectively mask taste and odor, and allow product visibility. These ca......
  • Global Compounding Pharmacy Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 25-May-2017        Price: US 3480 Onwards        Pages: 116
    The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example: A young child may need a small, liquid dose of a drug made only in adult-dosage tablets. A person may be allergic to one of the ingredients in the commercial version of a drug. A compounding pharmacy would make the proper dosage and form of the drug without any offending ......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 127
    In this report, the global Foot and Mouth Disease (FMD) Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Foot and Mouth Disease (FMD) Vaccines in these regions, from 2012 to 2022 (forecast), covering - North America......
  • Global Tourniquet Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 110
    In this report, the global Tourniquet market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Tourniquet in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan ......
  • 2017-2022 China Liquid Biopsy Products Market Report (Status and Outlook)
    Published: 24-May-2017        Price: US 3360 Onwards        Pages: 119
    "This report will be delivered in 2-3 business days after the order is placed." The Liquid Biopsy Products market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In China market, the top players include - RainDanceTechnologies - Biocartis - Qiagen - Guardant Health - MDxHealth - Pathway Genomics - NeoGe......
  • Global Solid Organ Transplant Immunosuppressant Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 109
    In this report, the global Solid Organ Transplant Immunosuppressant market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Solid Organ Transplant Immunosuppressant in these regions, from 2012 to 2022 (forecast), covering - North A......
  • Global Sufentanil (API) Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 102
    In this report, the global Sufentanil (API) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Sufentanil (API) in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - J......
  • Global Communicable Diseases Treatment Market Size, Status and Forecast 2022
    Published: 24-May-2017        Price: US 3300 Onwards        Pages: 106
    This report studies the global Communicable Diseases Treatment market, analyzes and researches the Communicable Diseases Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Bristol-Myers Squibb Pharmaceutical - Eli Lilly - GlaxoSmithKline - Johnson & Johnson - Medtronic - Merck - Pfizer - F. Hoffmann-La Roche - Sanofi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs